Thus, extracellular regucalcin may play a suppressive role in growth, migration, invasion, and adhesion, which are involved in the metastatic activity of human prostate cancer cells, via affecting various signaling pathways, providing a new strategy for preventing metastatic prostate cancer using exogenous regucalcin. Here, RGN is linked to prostate cancer.